Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

HOPE Therapeutics, wholly owned by NRx Pharmaceuticals (NRXP), announced signing of a binding Letter of Intent, LOI, to acquire a majority ...

The Mayo Clinic Center for Regenerative Biotherapeutics’ biomanufacturing capabilities help healthcare teams deliver next-generation treatments and cures for patients.